Clinical Trial Update: Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial in Chinese patients with essential hypertension evaluating the combination of benazepril and hydrochlorothiazide; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Benazepril (Benazepril)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED